Objective-Calpains, calcium-activated proteases, mediate the angiogenic signals of vascular endothelial growth factor.
C alpains are calcium-activated neutral cysteine proteases. 1, 2 Two major isoforms, calpain and m which require micromolar and millimolar Ca 2ϩ concentrations for activity, respectively, are ubiquitously expressed, whereas the other isoforms are tissue-specific forms. Their activity is limited by calpastatin, a specific endogenous inhibitor that contains 4 equivalent inhibitory domains. 1, 2 Calpains play an important role in inflammatory process. First, they are involved in the activation of NF-B, and thereby in the NF-B-dependent expression of proinflammatory cytokines and adhesion molecules. 3 Second, calpains are critical for inflammatory cell adhesion and chemotaxis and inflammatory mediator processing. 4, 5 Third, calpains are implicated in the cleavage of the heat shock protein 90, which is required for both binding and anti-inflammatory efficacy of glucocorticoids. 6 Finally, calpains are externalized during inflammatory process and play a role in the microenvironment of inflammatory cells. 7 We have recently demonstrated that calpains participate in the development of inflammatory lesions in an acute model of antiglomerular basement membrane nephritis. 8 In endothelial cells, calpain activity contributes to the hydrolysis of cytoskeletal proteins, 9 thereby facilitating shear stress-induced endothelial cell alignment, 10 and lymphocyte or leukocyte transendothelial migration. 11, 12 Importantly, vascular endothelial growth factor (VEGF) increases m-calpain expression and activity in those cells. [13] [14] [15] In turn, calpain activity participates in angiogenesis process, possibly by promoting cytoskeleton reorganization, 13 rear-cell detachment, 14 and/or nitric oxide generation. 15 However, whether activation of calpains plays any role in the vascular repair process besides the formation of new blood vessels is still unknown.
In severe and progressive kidney diseases, there is a rarefaction of peritubular capillaries which precedes the development of tubulo-interstitial fibrosis and the decline of renal function. 16 -20 This process is the hallmark of experimental and human kidney diseases regardless of their cause, such as antiglomerular basement membrane models of glomerulonephritis, anti-Thy-1.1 model of acute glomerulonephritis, remnant kidney model, aging associated renal disease, chronic cyclosporine A nephropathy, and kidney transplantation. 16, 17 Progressive loss of peritubular capillaries is explained by a decrease in postglomerular flow from diseased glomeruli and an inappropriate activation of endothelial cells by factors such as angiotensin II, which allows rolling and sticking of leukocytes, thus limiting oxygen delivery. 18, 19 Hypoxia and inflammatory conditions lead to endothelial cell death. Nevertheless, endothelium has a strong potential to regenerate via the proliferation of resident progenitors and/or the recruitment of circulating endothelial progenitor cells. 17 This angiogenesis process results from the local balance between pro-and antiangiogenic factors. 16 A loss of the angiogenic VEGF expression and a marked expression of the antiangiogenic factor thrombospondin-1 limit the repair of peritubular capillaries and promote the development of interstitial fibrosis. 21, 22 Herein we took advantage of transgenic mice constitutively expressing high levels of calpastatin 8 to study the impact of calpains/calpastatin balance on regeneration of peritubular capillaries in a severe model of antiglomerular basement membrane nephritis. Our results show that calpain activity is involved in this repair process. Surprisingly, extracellular calpains are particularly effective in capillary formation, suggesting that manipulation of calpain externalization rather than intracellular expression may have therapeutic implications to favor or inhibit angiogenesis.
Methods
Calpastatin transgenic (CalpTG) mice were created and characterized in the laboratory. 8 Glomerulonephritis was induced in male C57BL/6 wild type (WT) or CalpTG mice as described previously. 23 Renal injury was evaluated on days 7 and 14. Specimens of kidney were cut for histochemistry and immunohistochemistry studies. Calpain activity and expression were determined with a fluorescence assay described previously 8 and a Western assay, respectively. Human umbilical vein endothelial cells (HUVECs) were obtained to assess endothelial cell proliferation, monolayer repair, transmigration, and capillary formation.
For an expanded Materials and Methods, see the Supplemental Data, available online at http://atvb.ahajournals.org.
Results

CalpTG Mice Show a Defect in Both Formation of New Blood Vessels and Vascular Repair
To explore the importance of calpain/calpastatin balance in renal vascular repair, we compared WT and CalpTG mice. We first localized the transgene product in the kidney by immunohistochemistry ( Figure 1A ). Calpastatin expression was detectable in only a few tubules and in peritubular capillary cells. The intensity of this staining increased markedly in CalpTG as compared to WT mice. Then, to verify the role of calpain/calpastatin balance in the formation of new blood vessels in our mouse model, we used a Matrigel plug assay. 13, 24 Hemoglobin content in Matrigel plugs 10 days after subcutaneous injection, which measured blood vessel formation in the presence of VEGF-A, was significantly reduced in CalpTG as compared with WT recipients ( Figure  1B) . Finally, to assess the role of calpain/calpastatin balance in renal vascular repair, a rapidly progressive form of glomerulonephritis was induced in mice. Antiglomerular basement membrane serum (a total of 1.5 mg total protein/g body weight) was injected intravenously over 3 consecutive days, as previously described. 23 Survival curves show that the number of surviving mice decreased much more rapidly for CalpTG than WT mice (Supplemental Figure IA) . Blood urea nitrogen levels rose rapidly during the acute phase of immunologic injury until day 7 and then over the course of 14 days improved toward baseline values in WT mice while being even higher in CalpTG mice (Supplemental Figure IB) . . B, Angiogenesis was tested using an in vivo Matrigel plug assay. Ten days after subcutaneous injection of Matrigel with vascular endothelial growth factor, vessel invasion, as quantified by measuring hemoglobin content, was significantly limited in CalpTG (black bars) as compared to WT (gray bars) mice. *PϽ0.05, significant difference from WT. C, Fixed paraffin-embedded sections of kidney were stained with anti-mouse CD31 (PECAM) antibody. Peritubular capillary densities were quantified by measuring the number of capillary cross-sections per high power field. Significant capillary rarefaction observed 7 days after antiglomerular basement membrane (GBM) antiserum injection in all mice was reversed 7 days later in WT (gray bars) but not CalpTG mice (black bars). *PϽ0.05, significant difference from corresponding control at day 0; #PϽ0.005, significant difference from WT at day 14. D, Kidneys from WT and CalpTG mice were immunostained with anti-mouse panendothelial cell antigen antibody (MECA-32). Decreased peritubular capillary staining was observed 14 days after anti-GBM antiserum injection in CalpTG as compared to WT mice (Original magnification 200ϫ).
Peritubular capillary density was quantified in 2 ways after mouse CD31 (PECAM) or panendothelial cell antigen (MECA-32) immunostaining of endothelial cells. First, the mean number of capillary cross-sections per high power field (hpf) at 200ϫ magnification was measured in tubulointerstitial areas (Supplemental Figure IC-ID and Supplemental Figure II ). As expected, capillary density significantly decreased in all mice at day 7 after glomerulonephritis induction. One week later, this defect was reversed in WT mice while persisting in CalpTG mice. Second, peritubular capillary density was quantified by computer image analysis of MECA-32-stained area. At day 14, this area increased, consistent with capillary dilatation (Supplemental Figure II) . Again, such a staining pattern was significantly altered in CalpTG as compared to WT mice.
Altogether, these results underscore the involvement of calpains in vascular repair in addition to their established role in the formation of new blood vessels.
Extracellular Activity of Calpains Is Limited by Calpastatin Transgene Expression and Amplified by Proangiogenic Factors
Calpains are intracellular calcium-activated proteases that are partly externalized. 25 To assess the respective consequences of calpastatin transgene expression on intracellular and extracellular calpain activities, we decided to analyze both polyoma middle T-transformed mouse brain capillary endothelial cells (bEND.3 cells) transfected with the cDNA clone of rabbit calpastatin (PM 194) used to create CalpTG mice or control cDNA, and T cells isolated from the spleen of CalpTG and WT mice. Indeed, in contrast to microvascular endothelial cells, they are available without in vitro culture. 26 As assessed by measuring the calpain-specific cleavage of fluorescent 7-amino-4-methylcoumarin, 27 calpastatin excess limited both intracellular and extracellular calpain activities in both bEND.3 cells and T cells (Supplemental Figure III) . Thus, the lack of new blood vessel formation and vascular repair in CalpTG mice is potentially due to a decrease in intracellular and/or extracellular calpain activity.
Hypoxia and inflammatory conditions are responsible for the expression of a great diversity of proangiogenic factors including peptidic (eg, VEGF) and nonpeptidic (eg, norepinephrine) mediators. 28 To further identify the respective roles of intracellular and extracellular activities of calpains in angiogenesis process, we measured the effect of VEGF and norepinephrine on calpain activity and expression in HUVECs. Exposure of HUVEC to VEGF resulted in a dose-dependent increase of intracellular calpain activity with a maximal effective concentration of 10 to 50 ng/ml whereas norepinephrine had the opposite effect ( Figure 2A ). By contrast, either proangiogenic factor increased externalization of calpain activity ( Figure 2A ). The norepinephrine-mediated release of intracellular calpain activity into the extracellular milieu was not attributable to increased apoptosis or necrosis of the treated cells as evident by the similar percentage of mortality (propidium iodide-positive cells) of the norepinephrine-treated and control untreated cells (5.6Ϯ0.9 and 6.6Ϯ1.0, respectively). Externalization of calpain activity was associated with a rise in extracellular -calpain, a trend that did not achieve statistical significance and a statistically significant rise of m-calpain, as demonstrated by Western blot analysis ( Figure 2B ). Calpain secretion is thought to be in an unconventional way due to the lack of N-terminal classic secretion signal peptide. Underlying mechanisms are not known but might involve microparticle formation and shedding. 29, 30 To determine whether microparticles are carrying calpains, microparticles were isolated from the conditioned medium of norepinephrine-treated endothelial cells. They were identified by flow cytometry as events measuring 0.1 to 1.0 m that stained positive for annexin V bound to externalized phosphatidylserine (Supplemental Figure IV) . The -calpain was detectable in part of those microparticles. Our data suggest that the secreted form of calpains may be a critical component of angiogenesis process in response to VEGF and norepinephrine.
Extracellular Calpains Induce Endothelial Cell Proliferation, Migration, and Capillary Formation In Vitro and Ex Vivo
We therefore developed an in vitro model where HUVEC were exposed to exogenous -or m-calpain. We first mea- 
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sured the effect of calpain on DNA synthesis in HUVECs and found a dose-dependent increase with a maximal effective concentration of 1 g/ml ( Figure 3A) . Such a proliferative response, nearly comparable to that obtained with 2% serum, was dependent on the activity of the protease, because calpastatin addition blocked calpain effects (Supplemental Figure V) . Because both -and m-calpain accumulated in the culture medium of endothelial cells ( Figure 2B ), we addressed the respective contribution of either externalized calpain to the process of HUVEC proliferation. To this aim, HUVECs were cultured with endothelial cell conditioned media first depleted of -and/or m-calpain by absorption on Figure 3 . Effect of extracellular calpains on endothelial cell proliferation, migration, capillary formation, and microvessel outgrowth from mouse aortic explants. A, Human umbilical vein endothelial cells (HUVECs) (50ϫ10 3 cells/well) were cultured in basal medium with or without 2.0% fetal calf serum (FCS) or the indicated concentrations of -calpain (top; nϭ5) or with endothelial cell conditioned media (eCM) first depleted of -and/or m-calpain by absorption on wells coated with specific antibodies or nonspecific immunoglobulin G (IgG) (bottom; nϭ4). Additions were performed at 24 and 48 hours. BrdU was added to the wells at the later time. After further incubation (24 hours), DNA synthesis was measured using 5-bromo-2=-deoxyuridine assay kit. *PϽ0.05 and **PϽ0.005, significant difference from untreated cells (top) or cells treated with non depleted eCM (bottom). B, After a cell-free zone (0.5 mm) was created in the monolayer, HUVECs, were incubated for the indicated periods of time with (gray circles) or without (white circles) -calpain (2 g/mL). Thereafter, monolayer repair was measured and expressed as percentage of wound surface area (nϭ4). **PϽ0.01, significant difference from untreated cells. C, HUVECs in suspension were seeded on Matrigel and incubated for 20 hours with or without -calpain in the presence of 0.5% FCS and with or without calpeptin or calpastatin in the presence of 2.0% FCS. The density of formed tubes was analyzed by measuring total capillary length by high power field. (nϭ4 -6). *PϽ0.02 and ****PϽ0.0002, significant difference from untreated cells. D, Aortic explants from wild type (WT) or Calpastatin transgenic (CalpTG) mice adherent to Matrigel were treated as indicated for 7 days. Quantification of total microvessel outgrowth demonstrates a significant increase in aortic rings exposed to vascular endothelial growth factor (VEGF), norepinephrine (NE), or extracellular -calpain and, conversely, a significant decrease in aortic rings treated by extracellular calpastatin. (nϭ3-5). *PϽ0.05, significant difference from untreated aortic explants.
wells coated with specific antibodies. Both -and m-calpain depletion significantly limited DNA synthesis in HUVEC under these experimental conditions, and the effect of -calpain depletion was additive to that of m-calpain ( Figure  3A) . Thus, the 2 exteriorized calpains participate in endothelial cell proliferation.
Second, we analyzed the ability of HUVEC to migrate into a denuded area using a 2D scratch assay. Wound closure measured after 3, 6, and 9 hours was significantly faster after addition of calpain in the culture medium ( Figure 3B) .
Third, we examined the role the extracellular calpains play in the ability of endothelial cells to form vessels in vitro. HUVECs were incubated in Matrigel for 24 hours and endothelial tube formation was analyzed by measuring the total length of capillaries formed per high power field at 400ϫ magnification. Addition of calpain enhanced significantly endothelial cell tube formation, whereas, conversely, there was a reduction of serum-induced tube formation in the presence of factors inhibiting extracellular (non permeant calpastatin) and/or intracellular (calpeptin) calpain activity ( Figure 3C and Supplemental Figure VI) .
Finally, we measured the formation of vascular structures in an ex vivo sprouting assay. Addition of calpain to the culture medium resulted in increased sprouting from mouse aortic rings similar to that of VEGF and norepinephrine ( Figure 3D ). Conversely, endothelial sprout formation was limited by the presence of calpastatin or calpeptin.
Extracellular Calpains Induce Both Formation of New Blood Vessels and Vascular Repair In Vivo
As secreted calpains contribute to angiogenesis process in vitro, we needed to verify their specific role in new blood vessel formation in vivo. To this aim, we used again the Matrigel plug assay. Corresponding to Matrigel red colors, hemoglobin content and number of capillary cross-sections per high power field were significantly reduced after addition of calpastatin to the plugs ( Figure 4A ). Similarly, during wound healing process, local delivery of calpastatin significantly limited the formation of both blood and lymphatic vessels ( Figure 4B ).
Proangiogenic Function of Extracellular Calpains Involves Fibronectin Cleavage
Appearance of calpains in extracellular milieu leads potentially to proteolytic processing of a number of proteins at the surface of endothelial cells (eg, integrin subunits involved in endothelial cell attachment) and/or in extracellular matrix [eg, fibronectin (FN), laminin, and collagens]. Our previous studies indicated that extracellular calpains play a role in tubular epithelium regeneration after renal ischemia/reperfusion via the detachment of FN fragments from the extracellular matrix, 31 consistent with findings of other groups. 32 Thus, to identify molecular mechanisms whereby extracellular calpains speed up endothelium regeneration, we evaluated the ability of calpains to hydrolyze proteins of extracellular matrix in 1D SDS-PAGE experiments (Supplemental Figure  VII) . After exposure to human -calpain or porcine m-calpain, collagen I, collagen IV, and laminin remained intact. Intact human FN appeared with an apparent molecular weight (MW app .) Ͼ250 kDa. But additional protein bands with lower MW were also observed after incubation with calpain at MWϷ210 kDa and MWϷ140 kDa, respectively named (FNϩC1) A and (FNϩC1) B Table I ). The peptides mass fingerprint from (FNϩC1) A and (FNϩC1) B contained peptides only present in the C-terminal part of the FN compared to the peptides observed for the intact FN, which were located all Blood and lymphatic vessel surface and count were measured on wound sections (day 7) stained for CD31 (red), Lyve1 (green), and DAPI (blue). nϭ7 mice per group. Scale barϭ500 m. *PϽ0.05; **PϽ0.01; ***PϽ0.001 significant difference from wild type mice.
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along the sequence. Moreover, the MS/MS sequencing of peptides located in the C-terminal part of the intact FN, in position 1354 to 1382 and 1836 to 1859 in both proteins (FNϩC1) A and (FNϩC1) B confirmed that these truncated forms contained both the cell binding domain III 9 and the VEGF binding domain III 13 . 33 We next examined in vitro the effect of FN fragmentation on endothelial cell proliferation and migration. Figure 5A shows that -calpain-treated FN increased significantly VEGF-induced HUVEC proliferation while native FN did not. Moreover, calpains dramatically increased HUVEC migration, even significantly more compared with the native FN ( Figure 5B ). These data suggest an extracellular mechanism whereby externalized calpains induce endothelial cell mobilization in vitro and possibly angiogenesis and vascular repair in vivo.
Vascular Repair In Vivo Is Associated With FN Fragmentation
Because in vitro extracellular calpains generate FN fragments that promote endothelial cell proliferation and migration, we assessed the presence of such FN breakdown products in the kidney of mice at day 14 after glomerulonephritis induction, ie, at the time of vascular repair. Western blot analysis revealed an accumulation of Ϸ40 kDa FN breakdown product, which was significantly reduced in CalpTG as compared to WT mice ( Figure 6 ). These data are fully consistent with a role of calpain-dependent fragmentation of FN in vascular repair.
Discussion
This study demonstrates the involvement of calpains in vascular repair besides the formation of new blood vessels. Importantly, it is, to our knowledge, the first to uncover the role of exteriorized calpains in angiogenesis process both in vitro and in vivo. Additionally, we show that calpaindependent fragmentation of FN in extracellular matrix contributes to the induction of endothelial cell proliferation and migration in vitro. As a consequence, we propose that modification of calpain externalization is a potential target for either limiting angiogenesis (eg, in tumor development) or amplifying vascular repair (eg, in ischemia/inflammation).
To explore the role of calpains in vascular repair besides its known involvement in the formation of new blood vessels, we studied a model of loss of kidney capillaries. In progressive autologous/accelerated form of anti-glomerular basement membrane glomerulonephritis in mouse, rarefaction of peritubular capillaries causes peritubular ischemia that is responsible for tubulointerstitial damage, even more than proteinuria. 34 Here, anti-glomerular basement membrane antiserum was administered over 3 consecutive days, inducing also a severe accelerated form of glomerulonephritis. This model thus differs from that described in our previous study of calpain regulation 8 where a single injection of antiglomerular basement membrane antiserum caused a transient heterologous form of glomerulonephritis. Our present results demonstrate that limiting calpain activity by expressing calpastatin transgene does not affect the destruction but prevents completely the repair of peritubular capillaries, as assessed by 2 different techniques. Importantly, this is the first evidence to demonstrate the role of calpains in vascular repair besides neoangiogenesis. Further studies are clearly needed to understand the different downstream mechanisms involved in this process.
Up to now, studies performed mainly in vitro have implicated a role for intracellular calpains in angiogenesis. They mediate VEGF effects on cytoskeleton reorganization in endothelial cells, possibly through the activation of the Rho signaling pathway. 13 Ezrin, a protein involved in cytoskeletal remodeling, would contribute to calpain localization to plasma membrane and, hence, to VEGF-dependent activation of endothelial nitric oxide synthase. 15 As a consequence, endothelial NO production enhances endothelial cell migration, proliferation, and response to angiogenic factors. However, VEGF-induced calpain activity would also destabilize the microtubule skeleton, thereby preventing the integration of neovascular networks and causing the formation of vascular blind ends. 35 At variance with these previous studies, our own studies implicate calpain externalization as an important intermediate in angiogenesis process. Although calpains are considered as intracellular proteases, a few studies show that they are partly externalized. Obviously, calpains may leak out from injured and dying cells, but the release of intracellular calpains from lymphocytes 25 or parathyroid cells 30 among other cells is not due to cell death. The results of our study demonstrate for the first time the exteriorization of -calpain and m-calpain from endothelial cells in response to proangiogenic factors, VEGF, and norepinephrine. Calpastatin is not secreted under these conditions, consistent with our findings of an increase in extracellular activity of calpains. Surprisingly, VEGF increased and norepinephrine decreased calpain activity in endothelial cells. One possible interpretation of our data here is that VEGF activates intracellular calpain activity, possibly through an effect on membrane-specific localization rather than cell expression of calpains, 15 whereas norepinephrine limits intracellular calpain activity by increasing calpastatin expression, as shown in Western blot experiments. Actually, the fact that 2 main proangiogenic factors increase constant calpain exteriorization and not intracellular expression suggests that extracellular calpains participate in angiogenesis process, even if this role is not exclusive to them.
Our present in vitro studies strongly demonstrate an important contribution of exteriorized calpains as proangiogenic signals and as potential downstream effectors of different proangiogenic factors. Extracellular -and m-calpains promoted endothelial cell proliferation, migration, and capillary formation. Conversely, specific inhibition of extracellular calpains by calpastatin blunted serum-induce capillary formation from either endothelial cell suspensions or vessel explants. Next, experiments were performed to investigate signaling pathways that were associated with angiogenesis in response to extracellular calpains. Previous studies have suggested a role for protease-induced cleavage products of extracellular matrix proteins in vascular development and repair. 36 Because calpains are known to cleave FN, 31, 32 we focused our studies on this protein. Exposure of native human FN to calpains generated various fragments encompassing the C-terminal heparin-II domains 9 to 10 and 13 to 14 which bind the ␣ 5 ␤ 1 integrin and VEGF, respectively. Such cleavage products increased capillary formation in vitro significantly more than native FN did, confirming previous studies. 33 In addition, cleavage of FN by calpains would be a limiting factor of endothelial cell binding to extracellular matrix. Interestingly, a weakening of the linkage between extracellular matrix and the cytoskeleton of endothelial cells is sufficient to trigger an intracellular signaling cascade leading to capillary formation. 37 In the absence of subendothelial FN matrix, endothelial cells are thought to undergo a switch from ␣ 5 ␤ 1 to ␣ v ␤ 3 integrin-based adhesion, associated with a disruption of adherens junctions. 38 In turn, ␣ v ␤ 3 engagement promotes angiogenesis, in part via interaction with VEGF receptor 2. 39 Thus, FN cleavage by extracellular calpains would promote angiogenesis by both generating proangiogenic fragments and limiting FN adhesive functions.
Besides FN in the extracellular matrix, calpains are known to cleave latency-associated peptide and, hence, to activate transforming growth factor-␤ at the surface of endothelial cells. 40 As a consequence, mature transforming growth factor-␤ could promote angiogenesis through direct effects on endothelial cells and indirectly in stimulating VEGF synthesis by nonendothelial cells. 41 This intriguing possibility remains to be investigated.
The contribution of other potential mechanisms and their likely interaction with various signaling pathways in angiogenesis is difficult to evaluate in vitro. Thus, we tested in vivo whether inactivation of extracellular calpains by nonpermeant calpastatin would translate into deficiencies in angiogenesis and vascular repair. Once again, we showed that inhibition of extracellular calpains alone resulted in defect of capillary formation and vascular repair in Matrigel plug and skin wound healing models, respectively. In summary, the present studies provide evidence that calpain exteriorization from endothelial cells is induced by proangiogenic factors and is crucial for the angiogenesis process. They shed new light on the fundamental aspects of angiogenesis, adding a novel member to the list of extracellular proteases involved in angiogenesis, 42 and point to new directions in the exploration of therapeutic strategies.
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